Hengdian Group Capital
Hangzhouhengdiancapital.com
Overview
Hengdian Group Capital (HgC) is the strategic investment and corporate development arm of the Hengdian Group, a large Chinese conglomerate, focusing on investments in healthcare, advanced manufacturing, and entertainment sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Corxel | Jan 2026 | Series D Extension | Co-investor |
| Solu Therapeutics | Apr 2025 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.